K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENTLet's help them fight the urge to itchHill’s Derm Complete is formulated to help reduce allergic responses, including licking, scratching, headshaking and skin redness + Tell Me More